A rapid regioselective C3-functionalization of 7-phenylpyrazolo[1,5- a ]pyrimidines: en route to the synthesis of zaleplon and reversan drugs
Organic & Biomolecular Chemistry · 2026 · 24 (30) · 6250-6257
DOI: 10.1039/d6ob00761a ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic & Biomolecular Chemistry, 2026. Verfasst von Kshirsagar Prasad Suhas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad-500 037, India. shankar@niperhyd.ac…. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
A simple and sustainable C3-cyanation protocol for 7-phenylpyrazolo[1,5- a ]pyrimidines employing copper cyanide has been established and successfully applied to the synthesis of drug molecules including zaleplon and reversan.
Autor:innen und Institutionen
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad-500 037, India. shankar@niperhyd.ac.in.
Zitieren
APA
Suhas, K. P., Kumawat, A., Galla, M. S., & Shankaraiah, N. (2026). A rapid regioselective C3-functionalization of 7-phenylpyrazolo[1,5- a ]pyrimidines: en route to the synthesis of zaleplon and reversan drugs. Organic & Biomolecular Chemistry, 24(30), 6250-6257. https://doi.org/10.1039/d6ob00761a
Vancouver
Suhas KP, Kumawat A, Galla MS, Shankaraiah N. A rapid regioselective C3-functionalization of 7-phenylpyrazolo[1,5- a ]pyrimidines: en route to the synthesis of zaleplon and reversan drugs. Organic & Biomolecular Chemistry. 2026;24(30):6250-6257. doi:10.1039/d6ob00761a
BibTeX
@article{Suhas2026,
author = {Suhas, Kshirsagar Prasad and Kumawat, Akshay and Galla, Mary Sravani and Shankaraiah, Nagula},
title = {A rapid regioselective C3-functionalization of 7-phenylpyrazolo[1,5- a ]pyrimidines: en route to the synthesis of zaleplon and reversan drugs},
journal = {Organic & Biomolecular Chemistry},
year = {2026},
volume = {24},
number = {30},
pages = {6250--6257},
doi = {10.1039/d6ob00761a}
}
EUVIMED